论文部分内容阅读
Objective:To assess the safety and clinical antiangiogenic effect of recombinant adenovirus-p53(rAd-p53)combined with hyperthermia plus or not plus radiotherapy in advanced cancer.Methods:Expression of Vascular epithelial growth factor(VEGF)after intratum